Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.
暂无分享,去创建一个
W. Jacobs | P. Small | G. Hatfull | J. Sifuentes-Osornio | A. Ponce-de-León | N. Banaiee | M. Bobadilla-Del-Valle | P. Riska | S. Bardarov
[1] John Chan,et al. Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system. , 2003, Diagnostic microbiology and infectious disease.
[2] W. Jacobs,et al. Luciferase Reporter Mycobacteriophages for Detection, Identification, and Antibiotic Susceptibility Testing ofMycobacterium tuberculosis in Mexico , 2001, Journal of Clinical Microbiology.
[3] M. Espinal,et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[4] A. Khomenko,et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. , 2000, JAMA.
[5] M. Pagano,et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[6] G. Cangelosi,et al. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[7] M. Gismondo,et al. Multicenter Evaluation of the Mycobacteria Growth Indicator Tube for Testing Susceptibility of Mycobacterium tuberculosis to First-Line Drugs , 1999, Journal of Clinical Microbiology.
[8] T. Joint. Chemotherapy and management of tuberculosis in the United Kingdom : recommendations 1998 Joint Tuberculosis , 1998 .
[9] W. Jacobs,et al. Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone , 1997, Journal of clinical microbiology.
[10] D. Alland,et al. Improved outcomes for patients with multidrug-resistant tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] G. Sarkis,et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. , 1993, Science.
[12] J. T. Crawford,et al. The resurgence of tuberculosis: is your laboratory ready? , 1993, Journal of clinical microbiology.
[13] W. Gross,et al. Radiometric selective inhibition tests for differentiation of Mycobacterium tuberculosis, Mycobacterium bovis, and other mycobacteria , 1985, Journal of clinical microbiology.
[14] T. Timme,et al. Induction of bacteriophage from members of the Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium scrofulaceum serocomplex. , 1984, Journal of general microbiology.
[15] S. Siddiqi,et al. Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone , 1984, Journal of clinical microbiology.